Dosage unit comprising a prostaglandin analog for treating constipation
AssigneeSucampo AG
InventorsRyuji Ueno, Myra L. Patchen
Life of this patent
Estimating the term…
Abstract
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention includes a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects. In particular, the dosage unit includes a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains the PG analog in an amount of 24 μg+/−10%:
Claims13
A dosage unit comprising a prostaglandin (PG) analog represented by Formula (I) and/or its tautomers, and a pharmaceutically suitable excipient, wherein the dosage unit contains said PG analog in an amount of 24 μg+/−10%:
- where A1 and A2 are fluorine atoms and
- B is —COOH, including its pharmaceutically acceptable salts, esters or amides.
Dependencies are inferred from the claim text.